Publications by authors named "Hua Li Liu"

Precise control over the organic composition is crucial for tailoring the distinctive structures and properties of hybrid metal halides. However, this approach is seldom utilized to develop materials that exhibit stimuli-responsive circularly polarized luminescence (CPL). Herein, we present the synthesis and characterization of enantiomeric hybrid zinc bromides: biprotonated ((R/S)-CHN)ZnBr ((R/S-LH2)ZnBr) and monoprotonated ((R/S)-CHN)ZnBr ((R/S-LH1)ZnBr), derived from the chiral organic amine (R/S)-2,3,4,9-Tetrahydro-1H-carbazol-3-amine ((R/S)-CHN).

View Article and Find Full Text PDF

Stimuli-responsive circularly polarized luminescence (CPL) materials are ideal for information anti-countering applications, but the best-performing materials have not yet been identified. This work presents enantiomorphic hybrid antimony halides R-(C H NO) SbCl (1) and S-(C H NO) SbCl (2) showing mirror-imaged CPL activity with a dissymmetry factor of 1.2×10 .

View Article and Find Full Text PDF

Here, we synthesized a pair of chiral two-dimensional lead bromide perovskites -/-(CHNF)PbBr (1R/2S) using a H/F substitution strategy, which exhibit circular dichroism (CD) and circularly polarized luminescence (CPL) activity. Compared with one-dimensional non-centrosymmetric (CHN)PbBr with local asymmetry obtained by isopropylamine, 1R/2S show a centrosymmetric inorganic layer despite the global chiral space group. Density functional theory calculations show that the formation energy of 1R/2S is lower than that of (CHN)PbBr, which implies the improved moisture stability in photophysical properties and CPL activity.

View Article and Find Full Text PDF

A novel 0D organic-inorganic metal halide hybrid (CHNO)InCl·Cl (1) has been obtained by integrating the mono-viologen derivative with InCl. Compound 1 exhibits reversible and ultrafast UV/sunlight/X-ray induced photochromic properties, as well as excellent electrochromic performance, which is the first example of an indium-based organic-inorganic chromic hybrid.

View Article and Find Full Text PDF

Multiple randomized clinical trials have demonstrated that epidermal growth factor receptor (EGFR) exon 19 deletion (19Del) and exon 21 L858R mutation (L858R) are highly correlated with sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) treatment in non-small-cell lung cancer (NSCLC). A mutation in exon 20 (T790M) is reportedly associated with resistance to EGFR-TKIs. However, few studies have focused on patients harboring double mutations in these 3 mutation sites.

View Article and Find Full Text PDF

With the development of molecular pathology, many types of epidermal growth factor receptor (EGFR) mutations have been identified. The efficacy of EGFR tyrosine kinase inhibitors (EGFR-TKIs) in non-small cell lung cancer (NSCLC) patients with different types of EGFR mutations, especially in patients with single rare mutations or complex mutations (co-occurrence of two or more different mutations), has not been fully understood. This study aimed to examine the efficacy of EGFR-TKIs in NSCLC patients with different types of EGFR mutations.

View Article and Find Full Text PDF